Abstract
Islet-brain1 (IB1) or c-Jun NH2 terminal kinase interacting protein-1 (JIP-1), the product of the MAPK8IP1 gene, functions as a neuronal scaffold protein to allow signalling specificity. IB1/JIP-1 interacts with many cellular components including the reelin receptor ApoER2, the low-density lipoprotein receptor-related protein (LRP), kinesin and the Alzheimer's amyloid precursor protein. Coexpression of IB1/JIP-1 with other components of the c-Jun NH2 terminal-kinase (JNK) pathway activates the JNK activity; conversely, selective disruption of IB1/JIP-1 in mice reduces the stress-induced apoptosis of neuronal cells. We therefore hypothesized that IB1/JIP-1 is a risk factor for Alzheimer's disease (AD). By immunocytochemistry, we first colocalized the presence of IB1/JIP-1 with JNK and phosphorylated tau in neurofibrillary tangles. We next identified a −499A>G polymorphism in the 5' regulatory region of the MAPK8IP1 gene. In two separate French populations the −499A>G polymorphism of MAPK8IP1 was not associated with an increased risk to AD. However, when stratified on the +766C>T polymorphism of exon 3 of the LRP gene, the IB1/JIP-1 polymorphism was strongly associated with AD in subjects bearing the CC genotype in the LRP gene. The functional consequences of the -499A>G polymorphism of MAPK8IP1 was investigated in vitro. In neuronal cells, the G allele increased transcriptional activity and was associated with an enhanced binding activity. Taken together, these data indicate that the increased transcriptional activity in the presence of the G allele of MAPK8IP1 is a risk factor to the onset of in patients bearing the CC genotype of the LRP gene.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Davis RJ . Signal transduction by the JNK group of MAP kinases. Cell 2000; 103: 239–252.
Davis RJ . Signal transduction by the c-Jun N-terminal kinase. Biochem Soc Symp 1999; 64: 1–12.
Harper SJ, LoGrasso P . Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38. Cell Signal 2001; 13: 299–310.
Whitmarsh AJ, Davis RJ . Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals. Trends Biochem Sci 1998; 23: 481–485.
Dickens M, Rogers JS, Cavanagh J et al. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 1997; 277: 693–696.
Bonny C, Nicod P, Waeber G . IB1, a JIP-1-related nuclear protein present in insulin-secreting cells. J Biol Chem 1998; 273: 1843–1846.
Mooser V, Maillard A, Bonny C et al. Genomic organization, fine-mapping, and expression of the human islet-brain 1 (IB1)/c-Jun-amino-terminal kinase interacting protein-1 (JIP-1) gene. Genomics 1999; 55: 202–208.
Whitmarsh AJ, Cavanagh J, Tournier C, Yasuda J, Davis RJ . A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 1998; 281: 1671–1674.
Harding TC, Xue L, Bienemann A et al. Inhibition of JNK by overexpression of the JNL binding domain of JIP-1 prevents apoptosis in sympathetic neurons. J Biol Chem. 2001; 276: 4531–4534.
Tawadros T, Formenton A, Dudler J et al. The scaffold protein IB1/JIP-1 controls the activation of JNK in rat stressed urothelium. J Cell Sci 2002; 115: 385–393.
Whitmarsh AJ, Kuan CY, Kennedy NJ et al. Requirement of the JIP1 scaffold protein for stress-induced JNK activation. Genes Dev 2001; 15: 2421–2432.
Thompson NA, Haefliger JA, Senn A et al. Islet-brain1/JNK-interacting protein-1 is required for early embryogenesis in mice. J Biol Chem 2001; 276: 27745–27748.
Stockinger W, Brandes C, Fasching D et al. The reelin receptor ApoER2 recruits JNK-interacting proteins-1 and -2. J Biol Chem 2000; 275: 25625–25632.
Gotthardt M, Trommsdorff M, Nevitt MF et al. Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction. J Biol Chem 2000; 275: 25616–25624.
Meyer D, Liu A, Margolis B . Interaction of c-Jun aminoterminal kinase interacting protein-1 with p190 rhoGEF and its localization in differentiated neurons. J Biol Chem 1999; 274: 35113–35118.
Verhey KJ, Meyer D, Deehan R et al. Cargo of kinesin identified as jip scaffolding proteins and associated signaling molecules. J Cell Biol 2001; 152: 959–970.
Matsuda S, Yasukawa T, Homma Y et al. c-Jun n-terminal kinase (jnk)-interacting protein-1b/islet-brain-1 scaffolds alzheimer's amyloid precursor protein with jnk. J Neurosci 2001; 21: 6597–6607.
Taru H, Kirino Y, Suzuki T . Differential roles of JIP scaffold proteins in the modulation of amyloid precursor protein metabolism. J Biol Chem 2002; 277: 27567–27574.
Lambert JC, Mann D, Goumidi L et al. A FE65 polymorphism associated with risk of developing sporadic late- onset alzheimer's disease but not with Abeta loading in brains. Neurosci Lett 2000; 293: 29–32.
Baum L, Chen L, Ng HK et al. Low density lipoprotein receptor related protein gene exon 3 polymorphism association with Alzheimer's disease in Chinese. Neurosci Lett 1998; 247: 33–36.
Lendon CL, Talbot CJ, Craddock NJ et al. Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population. Neurosci Lett 1997; 222: 187–190.
Lambert JC, Chartier-Harlin MC, Cottel D et al. Is the LDL receptor-related protein involved in Alzheimer's disease? Neurogenetics . 1999; 2: 109–113.
Herz J, Beffert U . Apolipoprotein E receptors: linking brain development and Alzheimer's disease. Nat Rev Neurosci 2000; 1: 51–58.
Hollenbach E, Ackermann S, Hyman BT, Rebeck GW . Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease. Neurology 1998; 50: 1905–1907.
Pellet JB, Haefliger JA, Staple JK et al. Spatial, temporal and subcellular localization of islet-brain 1 (IB1), a homologue of JIP-1, in mouse brain. Eur J Neurosci 2000; 12: 621–632.
Hayashi T, Sakai K, Sasaki C, Zhang WR, Warita H, Abe K . c-Jun N-terminal kinase (JNK) and JNK interacting protein response in rat brain after transient middle cerebral artery occlusion. Neurosci Lett 2000; 284: 195–199.
Gillardon F, Spranger M, Tiesler C, Hossmann KA . Expression of cell death-associated phospho-c-Jun and p53-activated gene 608 in hippocampal CA1 neurons following global ischemia. Brain Res Mol Brain Res 1999; 73: 138–143.
Bonny C, Oberson A, Steinmann M, Schorderet DF, Nicod P, Waeber G . IB1 reduces cytokine-induced apoptosis of insulin-secreting cells. J Biol Chem 2000; 275: 16466–16472.
Bonny C, Oberson A, Negri S, Sauser C, Schorderet DF . Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes. 2001; 50: 77–82.
Barr RK, Kendrick TS, Bogoyevitch MA . Identification of the critical features of a small peptide inhibitor of JNK activity. J Biol Chem 2002; 277: 10987–10997.
Xia XG, Harding T, Weller M, Bieneman A, Uney JB, Schulz JB . Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease. Proc Natl Acad Sci USA 2001; 98: 10433–10438.
Waeber G, Delplanque J, Bonny C et al. The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes. Nat Genet 2000; 24: 291–295.
Amouyel P, Richard F, Cottel D, Amant C, Codron V, Helbecque N . The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment. Neurosci Lett 1996; 217: 203–205.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939–944.
Braak H, Braak E . Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991; 82: 239–259.
Abderrahmani A, Steinmann M, Plaisance V et al. The transcriptional repressor REST determines the cell-specific expression of the human MAPK8IP1 gene encoding IB1 (JIP-1). Mol Cell Biol 2001; 21: 7256–7267.
Riederer BM, Mourton-Gilles C, Frey P, Delacourte A, Probst A . Differential phosphorylation of tau proteins during kitten brain development and Alzheimer's disease. J Neurocytol 2001; 30: 145–158.
Buee-Scherrer V, Condamines O, Mourton-Gilles C et al. AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease. Brain Res Mol Brain Res 1996; 39: 79–88.
Delacourte A, David JP, Sergeant N et al. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology. 1999; 52: 1158–1165.
Hashimoto M, Hsu LJ, Rockenstein E, Takenouchi T, Mallory M, Masliah E . alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells. J Biol Chem 2002; 277: 11465–11472.
Trommsdorff M, Gotthardt M, Hiesberger T et al. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 1999; 97: 689–701.
Howell BW, Herz J . The LDL receptor gene family: signaling functions during development. Curr Opin Neurobiol 2001; 11: 74–81.
Willnow TE, Nykjaer A, Herz J . Lipoprotein receptors: new roles for ancient proteins. Nat Cell Biol 1999; 1: E157–E162.
Helbecque N, Richard F, Cottel D, Neuman E, Guez D, Amouyel P . The very low density lipoprotein (VLDL) receptor is a genetic susceptibility factor for Alzheimer disease in a European Caucasian population. Alzheimer Dis Assoc Disord 1998; 12: 368–371.
Sanchez-Guerra M, Combarros O, Infante J et al. Case-control study and meta-analysis of low density lipoprotein receptor-related protein gene exon 3 polymorphism in Alzheimer's disease. Neurosci Lett 2001; 316: 17–20.
Clement K, Ruiz J, Cassard-Doulcier AM et al. Additive effect of A–>G (-3826) variant of the uncoupling protein gene and the Trp64Arg mutation of the beta 3-adrenergic receptor gene on weight gain in morbid obesity. Int J Obes Relat Metab Disord 1996; 20: 1062–1066.
Rosmond R, Chagnon M, Bouchard C, Bjorntorp P . A polymorphism in the regulatory region of the corticotropin-releasing hormone gene in relation to cortisol secretion, obesity, and gene–gene interaction. Metabolism 2001; 50: 1059–1062.
Kang DE, Pietrzik CU, Baum L et al. Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. J Clin Invest 2000; 106: 1159–1166.
Bennett BL, Sasaki DT, Murray BW et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 2001; 98: 13681–13686.
Acknowledgements
This work was supported by grants from the Swiss National Science Foundation (32-62623.00 to GW, 31-56689.99 to JAH, 32-61623.00 to VM), the Juvenile Diabetes Research Foundation (1-2001-555 to GW), the Placide Nicod and the Octav and Marcella Botnar Foundations, the Caisse Nationale d'Assurance Maladie des Travailleurs Salariés (701036), the Institut National de la Santé et de la Recherche Médicale (Réseau de Recherche en Santé Publique no. 494004), the CH et U de Lille and the Institut Pasteur de Lille. We thank all the Directors and Physicians of the retirement homes and Dr MT Hurtevent without whom this work would not have been possible. We thank Xavier Hermant and Sophie Machelart for skillful technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Helbecque, N., Abderrhamani, A., Meylan, L. et al. Islet-brain1/C-Jun N-terminal kinase interacting protein-1 (IB1/JIP-1) promoter variant is associated with Alzheimer's disease. Mol Psychiatry 8, 413–422 (2003). https://doi.org/10.1038/sj.mp.4001344
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001344
Keywords
This article is cited by
-
Lrrk2 and chronic inflammation are linked to pallido-ponto-nigral degeneration caused by the N279K tau mutation
Acta Neuropathologica (2007)
-
Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease
Molecular Psychiatry (2006)